Tadataka Yamada Prometheus Biosciences, Inc. (RXDX) insider trading activity

RXDX Quotes by TradingView

Tadataka Yamada is Director of Prometheus Biosciences, Inc.. Currently has a direct ownership of 13,333 shares of RXDX, which is worth approximately $0. The most recent transaction as insider was on Mar 16, 2021, when has been sold 13,333 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.3K
0% 3M change
0% 12M change
Total Value Held $0

Tadataka Yamada Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 16 2021
BUY
Conversion of derivative security
-
13,333 Added 50.0%
13,333 Common Stock

Also insider at

PHAT
Phathom Pharmaceuticals, Inc. Healthcare
Director
PASG
Passage BIO, Inc. Healthcare
Director
ATHA
Athira Pharma, Inc. Healthcare
Director
TY

Tadataka Yamada

Director
San Diego, CA

Track Institutional and Insider Activities on RXDX

Follow Prometheus Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXDX shares.

Notify only if

Insider Trading

Get notified when an Prometheus Biosciences, Inc. insider buys or sells RXDX shares.

Notify only if

News

Receive news related to Prometheus Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXDX